Context Bladder cancer (BC) represents a significant health problem due to the potential
morbidity and mortality associated with disease burden, which has remained largely …

Importance Bladder cancer is a common malignancy in women and is the fourth most
common malignancy in men. Bladder cancer ranges from unaggressive and usually …

Background To measure the quality of care for lip and oral cavity cancer worldwide using the
data from the Global Burden of Disease (GBD) Study 2017. Methods After devising four main …

Objective Among patients diagnosed with non-muscle invasive bladder cancer (NMIBC),
those with high risk disease have the greatest risk of recurrence and disease progression …

Introduction: Metabolomics is a chemical process, involving the characterization of
metabolites and cellular metabolism. Recent studies indicate that numerous metabolic …

Neoadjuvant cisplatin-based chemotherapy (NACC) followed by radical cystectomy is the
standard treatment for localized muscle-invasive bladder cancer (MIBC). Patients who …

ABSTRACT Introduction and Objectives Prior work has demonstrated racial disparities in
surgical outcomes for solid organ cancers. We sought to assess the relationship between …

Introduction It is unknown whether race/ethnicity affects access and/or survival after
neoadjuvant (NAC) or adjuvant chemotherapy (ADJ) at radical cystectomy (RC). We …

Background: Radical cystectomy (RC) is considered a complex procedure that entails
significant morbidity and mortality. Objectives: We aimed to determine pre-operative patient …

Purpose Treatment delays in muscle invasive bladder cancer (MIBC) have been shown to
be associated with worse outcomes. While every attempt is made to provide adequate …